Correlation Between Qualigen Therapeutics and Burberry Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and Burberry Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and Burberry Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qualigen Therapeutics and Burberry Group Plc, you can compare the effects of market volatilities on Qualigen Therapeutics and Burberry Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of Burberry Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and Burberry Group.

Diversification Opportunities for Qualigen Therapeutics and Burberry Group

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Qualigen and Burberry is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and Burberry Group Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Burberry Group Plc and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with Burberry Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Burberry Group Plc has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and Burberry Group go up and down completely randomly.

Pair Corralation between Qualigen Therapeutics and Burberry Group

Given the investment horizon of 90 days Qualigen Therapeutics is expected to generate 1.53 times more return on investment than Burberry Group. However, Qualigen Therapeutics is 1.53 times more volatile than Burberry Group Plc. It trades about 0.0 of its potential returns per unit of risk. Burberry Group Plc is currently generating about -0.06 per unit of risk. If you would invest  411.00  in Qualigen Therapeutics on December 30, 2024 and sell it today you would lose (31.00) from holding Qualigen Therapeutics or give up 7.54% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Qualigen Therapeutics  vs.  Burberry Group Plc

 Performance 
       Timeline  
Qualigen Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Qualigen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Qualigen Therapeutics is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Burberry Group Plc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Burberry Group Plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental drivers remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Qualigen Therapeutics and Burberry Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Qualigen Therapeutics and Burberry Group

The main advantage of trading using opposite Qualigen Therapeutics and Burberry Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, Burberry Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Burberry Group will offset losses from the drop in Burberry Group's long position.
The idea behind Qualigen Therapeutics and Burberry Group Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins